Vima Therapeutics

Cambridge, Massachusetts, United States · Biotechnology, Health Care, Therapeutics · 35 employees

Vima Therapeutics is a clinical-stage biotechnology company providing treatments for dystonia and related movement disorders. The company is advancing an oral therapy designed to help patients improve control of their movement by targeting the root cause of the disease. It is currently working on VIM0423, a potential first-in-class oral therapy, which is in a Phase 1 clinical trial with plans to m

See plans & pricing → Track Vima Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.